Recent research data surrounding the medication Retatrutide , specifically the high-dose formulation ZPHC ZPHC, suggest a significant effect on weight reduction and linked metabolic conditions . Experts posit that this combined acting , affecting both GLP-1 and GIP receptors , could provide a maj